VEGFA and urinary bladder carcinoma: sEphB4-HSA was also combined with VEGF neutralizing antibody bevacizumab based on our bladder cancer tissue analysis showing that bladder cancers express VEGFR2 at both the tumor vasculature as well as the tumor cells in some of the cases [32].